The effect of a semi-permeable, strengthening fiber coating on the expansion, mechanical properties, and residence time of gastroretentive fibrous dosage forms-Reference-Cited by-同舟云学术

The effect of a semi-permeable, strengthening fiber coating on the expansion, mechanical properties, and residence time of gastroretentive fibrous dosage forms

Published:2022-12 Issue: Volume: Page:122378
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Blaesi Aron H.,Echtermann Thomas,Richter Henning,Saka Nannaji

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference29 articles.

1. The mechanical properties of cellular solids;Ashby;Metall. Trans. A,1983

2. Atkins, P.W., 1994. Physical Chemistry, fifth ed. Oxford University Press, Oxford, UK, pp. 227-228, 846-849.

3. Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals;Bellinger;Sci. Trans. Med.,2016

4. Determination of the mechanical properties of solid and cellular polymeric dosage forms;Blaesi;Int. J. Pharm.,2016

5. 3D-micro-patterned fibrous dosage forms for immediate drug release;Blaesi;Mater. Sci. Eng. C,2018

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 4: Experimental validation of the models of drug concentration in blood;International Journal of Pharmaceutics;2024-06

2. Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 3: Theoretical models of drug concentration in blood;International Journal of Pharmaceutics;2024-06

3. Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 2: Experimental validation of the models of expansion, post-expansion mechanical strength, and drug release;International Journal of Pharmaceutics;2024-06

4. Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 1: Dosage form design, and models of expansion, post-expansion mechanical strength, and drug release;International Journal of Pharmaceutics;2024-06

5. Rolled-up gastroretentive oral dosages for controlled release of riboflavin and propranolol;Journal of Drug Delivery Science and Technology;2024-05